Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051220 · ClinicalTrials.gov registry record · Phase 1
Treatment for Specific Phobias in Children
A Phase 1 study of Anxiety Disorders and Phobic Disorders, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT00051220 is a Phase 1 study of Anxiety Disorders and Phobic Disorders that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 150 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00051220, a Phase 1 study of Anxiety Disorders and Phobic Disorders, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.
Conditions Studied
Interventions
- BEHAVIORAL One-Session Treatment for Specific Phobias
Study Locations (2)
Virginia
- VA Polytech. Institute and State University - Blacksburg
Other
- University of Stockholm - Stockholm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2001-10 |
| Est. Completion | 2006-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00051220
The ClinicalTrials.gov registry entry for NCT00051220 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (87% lower). The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which One-Session Treatment for Specific Phobias is the first listed.
NCT00051220 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Virginia, Other.
Frequently Asked Questions
What is clinical trial NCT00051220 about?
NCT00051220 is a clinical study titled "Treatment for Specific Phobias in Children". This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.
What is the current status of trial NCT00051220?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2001-10. Estimated completion is 2006-09.
What conditions does trial NCT00051220 study?
This clinical trial studies the following conditions: Anxiety Disorders, Phobic Disorders.
What interventions are being tested in trial NCT00051220?
The interventions under investigation include: One-Session Treatment for Specific Phobias (BEHAVIORAL).
Who is sponsoring clinical trial NCT00051220?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00051220 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
COMPLETED · Phase 1
-
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
COMPLETED · Phase 1
-
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
COMPLETED · Phase 1
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.